Design strategies and recent development of bioactive modulators for glutamine transporters

• DOI: 10.1016/j.drudis.2024.103880
• Publication Date: 2024-01-11T07:38:45Z
• Authors: Xinying Cheng; Yezhi Wang; Guangyue Gong; Pei Shen; Zhiyu Li; Jinlei Bian
• Keywords: Drug Development

Glutamine transporters are integral to the metabolism of glutamine in both healthy tissues and cancerous cells, playing a pivotal role in maintaining amino acid balance, synthesizing biomolecules, and regulating redox equilibrium. Their critical functions in cellular metabolism make them promising targets for oncological therapies. Recent years have witnessed substantial progress in the field of glutamine transporters, marked by breakthroughs in understanding of their protein structures and the discovery of novel inhibitors, prodrugs, and radiotracers. This review provides a comprehensive update on the latest advancements in modulators targeting the glutamine transporter, with special attention given to LAT1 and ASCT2. It also discusses innovative approaches in drug design aimed at these transporters.